BrightSpring Health Services (BTSG) CFO sells 35,000 shares, receives RSUs

Filing Impact

(Very High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

BrightSpring Health Services Chief Financial Officer Jennifer A. Phipps reported multiple equity transactions. She sold 35,000 shares of common stock at $41.15 per share in a registered public offering that closed on March 4, 2026, while exercising 35,000 stock options at $6.37 per share.

She also acquired several equity awards. On March 5, 2026, she received 53,384 restricted stock units that vest in three equal annual installments beginning on January 25, 2027. Performance-based stock options granted in 2019 and 2020 vested after performance conditions were satisfied, and additional options vest over three years starting January 25, 2027. Following these transactions, she directly owned 196,840 shares of common stock and 130,860 stock options.

Insider Trade Summary

Net Seller: 35,000 shares ($1,440,250)

Net Sell 7 txns

Insider Phipps Jennifer A

Role Chief Financial Officer

Sold 35,000 shs ($1.44M)

Type	Security	Shares	Price	Value
Grant/Award	Stock Options (Right to Buy)	130,860	$0.00	--
Grant/Award	Common Stock	53,384	$0.00	--
Grant/Award	Stock Options (Right to Buy)	35,331	$0.00	--
Grant/Award	Stock Options (Right to Buy)	5,888	$0.00	--
Exercise	Stock Options (Right to Buy)	35,000	$0.00	--
Exercise	Common Stock	35,000	$6.37	$223K
Sale	Common Stock	35,000	$41.15	$1.44M

Holdings After Transaction: Stock Options (Right to Buy) — 130,860 shares (Direct); Common Stock — 250,224 shares (Direct)

Footnotes (1)

These shares of the Issuer's common stock were sold by the Reporting Person pursuant to a registered public offering that closed on March 4, 2026, at a price of $41.15, before deducting underwriting discounts and commissions. On March 5, 2026, the Reporting Person was granted restricted stock units ("RSUs") which vest in three equal annual installments commencing on January 25, 2027. Each RSU represents a contingent right to receive one share of common stock upon settlement. No new stock options have been awarded. The transaction reported herein reflects vesting of performance-based stock options ("2019 Performance Options") previously awarded to the Reporting Person on September 24, 2019, vesting subject to performance conditions that were subsequently satisfied on March 4, 2026. The 2019 Performance Options are fully vested. No new stock options have been awarded. The transaction reported herein reflects vesting of performance-based stock options ("2020 Performance Options") previously awarded to the Reporting Person on May 12, 2020, vesting subject to performance conditions that were subsequently satisfied on March 4, 2026. The 2020 Performance Options are fully vested. These options are fully vested. Options vest in three equal annual installments commencing on January 25, 2027.

Form 4 Insider Transactions: What Each Field Means →

03/06/2026 - 07:45 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Phipps Jennifer A

(Last)

(First)

(Middle)

C/O BRIGHTSPRING HEALTH SERVICES, INC.

805 N. WHITTINGTON PARKWAY

(Street)

LOUISVILLE

40222

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
BrightSpring Health Services, Inc. [ BTSG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/04/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/04/2026		M		35,000	A	$6.37	231,840	D
Common Stock	03/04/2026		S⁽¹⁾		35,000	D	$41.15⁽¹⁾	196,840	D
Common Stock	03/05/2026		A⁽²⁾		53,384	A	$0	250,224	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Options (Right to Buy)	$6.37	03/04/2026		A		35,331		⁽³⁾	09/24/2029	Common Stock	35,331	$0	125,708	D
Stock Options (Right to Buy)	$7.01	03/04/2026		A		5,888		⁽⁴⁾	05/12/2030	Common Stock	5,888	$0	23,543	D
Stock Options (Right to Buy)	$6.37	03/04/2026		M			35,000	⁽⁵⁾	09/24/2029	Common Stock	35,000	$0	90,708	D
Stock Options (Right to Buy)	$41.77	03/05/2026		A		130,860		⁽⁶⁾	03/05/2036	Common Stock	130,860	$0	130,860	D

Explanation of Responses:

1. These shares of the Issuer's common stock were sold by the Reporting Person pursuant to a registered public offering that closed on March 4, 2026, at a price of $41.15, before deducting underwriting discounts and commissions.

2. On March 5, 2026, the Reporting Person was granted restricted stock units ("RSUs") which vest in three equal annual installments commencing on January 25, 2027. Each RSU represents a contingent right to receive one share of common stock upon settlement.

3. No new stock options have been awarded. The transaction reported herein reflects vesting of performance-based stock options ("2019 Performance Options") previously awarded to the Reporting Person on September 24, 2019, vesting subject to performance conditions that were subsequently satisfied on March 4, 2026. The 2019 Performance Options are fully vested.

4. No new stock options have been awarded. The transaction reported herein reflects vesting of performance-based stock options ("2020 Performance Options") previously awarded to the Reporting Person on May 12, 2020, vesting subject to performance conditions that were subsequently satisfied on March 4, 2026. The 2020 Performance Options are fully vested.

5. These options are fully vested.

6. Options vest in three equal annual installments commencing on January 25, 2027.

	/s/ Jennifer Phipps	03/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did BrightSpring (BTSG) CFO Jennifer Phipps sell in this Form 4?

BrightSpring CFO Jennifer A. Phipps sold 35,000 shares of common stock at $41.15 per share. The sale occurred in connection with a registered public offering that closed on March 4, 2026, following the exercise of 35,000 stock options at $6.37 per share.

What equity awards did the BrightSpring (BTSG) CFO receive?

Jennifer A. Phipps received several equity awards, including 53,384 restricted stock units on March 5, 2026. These RSUs vest in three equal annual installments starting on January 25, 2027. She also had performance-based stock options granted in 2019 and 2020 vest after meeting performance conditions.

How many BrightSpring (BTSG) shares does the CFO own after these transactions?

After the reported transactions, Jennifer A. Phipps directly owned 196,840 shares of BrightSpring common stock. In addition, she held 130,860 stock options following the latest option-related transactions, combining vested performance-based options and options scheduled to vest over three years beginning January 25, 2027.

How do the BrightSpring (BTSG) RSUs for the CFO vest over time?

The 53,384 restricted stock units granted to Jennifer A. Phipps on March 5, 2026 vest in three equal annual installments. Vesting begins on January 25, 2027, with each RSU representing a contingent right to receive one share of BrightSpring common stock upon settlement.

What are the details of the CFO’s performance-based stock options at BrightSpring (BTSG)?

The filing notes performance-based stock options granted on September 24, 2019, and May 12, 2020. Their vesting depended on performance conditions that were satisfied on March 4, 2026, making both the 2019 and 2020 performance option grants fully vested as of that date.

Were any of the BrightSpring (BTSG) CFO stock options newly awarded?

The filing clarifies that certain reported option transactions do not represent new awards. Instead, they reflect the vesting of performance-based stock options granted in 2019 and 2020 after performance conditions were met, and the options described in one footnote are already fully vested.